Objective: To determine the effects of human immunodeficiency virus (HIV) infection on children's development by identifying neurological and environmental variables associated with neuropsychological measures of cognitive development in HIV-seronegative (HIV-) and HIV-seropositive (HIV+) children and adolescents with hemophilia.
is wide variability in the nature and severity of symptoms of pediatric HIV disease. Some children show rapid declines in several areas of functioning, while others suffer less profound impairment or show development within age expectations. Several developmental courses have been identified in children infected perinatally, including a progressive encephalopathy characterized by acquired microcephaly, motor dysfunction, and loss of previously acquired skills (Belman, 1994; Brouwers, Belman, & Epstein, 1991) . Structural changes such as cerebral atrophy, white matter abnormalities, and calcification of the basal ganglia have been found in many cases as well. The relationship of these changes to functional impairment is not well understood. Studies of children infected postnatally through contaminated blood products, for example, via transfusions received in the neonatal period (Cohen, Mundy, Karassik, Lieb, Ludwig, & Ward, 1991) or through blood products required for treatment of hemophilia (Sirois & Hill, 1993; Whitt et al., 1993) , show that children who are medically asymptomatic perform within age expectations on measures of cognitive functioning. There is currently a lack of information about the long-term effects of HIV infection in children and adolescents who remain asymptomatic or who do not meet criteria for a diagnosis of acquired immunodeficiency syndrome (AIDS).
Cognitive changes in otherwise asymptomatic HIV-infected individuals are associated with direct infection of the brain (Brouwers et al., 1991) . It is well known that the central nervous system (CNS) is infected early in the course of pediatric HIV disease (Perry, 1990) , but the neurophysiological processes underlying the disease remain unclear because of the lack of prospective studies and the differences in method among studies (Nozyce, Hittelman, Muenz, Durako, Fischer, & Willoughby, 1994) . Our understanding of the processes underlying HIV disease would be advanced through a study of children who were infected with HIV postinfancy when the rate of brain growth is slowing and who acquired the infection at different stages of neurodevelopment.
The Hemophilia Growth and Development Study (HGDS) was designed to address such questions. A prospective, multicenter research design was employed to study children and adolescents with two chronic illnesses, hemophilia and HIV infection. Longitudinal assessments of physical growth and development, of immunologic status, and of changes in the CNS (as measured by neurological examinations, magnetic resonance imaging [MRI] , electroencephalography [EEG] , and neuropsychological evaluations) were designed to determine what relationships exist among these systems and to improve our understanding of the influences of HIV and of hemophilia on children's development. Children and adolescents with hemophilia are unique in their potential for contribution to an understanding of HIV disease. Families with hemophilia generally live without the environmental risk factors and social stressors present for infants born to mothers who themselves were infected at their child's birth, for example, severe poverty and parental drug abuse. Children with hemophilia usually receive regular medical care through an established system of hemophilia care centers where psychological and social services may be provided, thus reducing the potential for impairment resulting from lack of care. Children with hemophilia and HIV were infected during the developmental periods between infancy and young adulthood, during a known time interval (primarily in the early 1980s), and through a known route of transmission (contaminated blood products). The HGDS has a further advantage for HIV research in that approximately 90% of the HIV-seropositive participants entered the study without a previous diagnosis of AIDS as defined by the CDC in 1987 (CDC, 1987) , thus providing a relatively healthy group of study participants.
In this paper we report interrelationships among results obtained at baseline from the neurological and neuropsychological components of the HGDS. The objective of the analysis was to identify the neurological and environmental variables associated with measures of cognitive functioning for the HIV-seronegative (HIV-) and HIV-seropositive (HIV+) study participants in order to understand the early development of HIV disease. The hypotheses were:
1. The HIV+ participants will show more neurological and neuropsychological impairments than the HIV-participants, and, for the HIV+ participants, a condition of greater immunosuppression will be associated with greater neurological and neuropsychological impairment; 2. Neuropsychological performance will be lower for participants who show abnormalities on the neurological examination relative to those who do not, regardless of HIV status; 3. Interactions among the HIV, neurological, and environmental variables, when analyzed to-gether, will reveal patterns of influence on neuropsychoiogical performance.
Method

Participants and Setting
Participants in the HGDS were recruited from 14 comprehensive hemophilia treatment centers in the United States. Eligibility criteria included a birthdate between 9/1/70 and 9/1/82, factor use indicative of moderate to severe hemophilia, and fluency in the English language (to standardize neuropsychoiogical test procedures). Baseline data were collected at the hemophilia centers between March 1989 and June 1990. All data were recorded on forms developed for this study, including data obtained from standardized measures used in the protocol. Institutional Review Board (IRB) approval for protection of human subjects was obtained at all centers. Written informed consent and assent was obtained from each participant, parent, or legal guardian, as appropriate and according to local IRB requirements. Details of the design, methods, and data management strategies are presented in Hilgartner et al. (1993) and Stehbens et al. (1997) .
The hemophilic cohort of the HGDS (N = 333) is representative of the total population of children and adolescents with moderate to severe hemophilia identified in the census at each participating center with respect to race and ethnicity, type and severity of hemophilia, and factor usage (Hilgartner et al., 1993) . Of 333 participants, 298 completed all of the baseline measures required for the present analysis (neurological and neuropsychoiogical examinations, MRI, and EEG) and had valid neuropsychoiogical test scores. All were male, ages 7-19 years at baseline. Approximately 74% of the sample had clotting factor levels below 1%; 19.1% had factor levels of 1-5%; and 6.8% had factor levels above 5%. Three categories of HIV status were defined: HIV-(n = 120), HIV+ with CD4+ count 2 200 cells/mm 3 (CD4 > 200, n = 128), and HIV+ with CD4+ count < 200 cells/mm 3 (CD4 < 200, n = 50).
The 35 participants excluded from the present analysis were excluded because of missing data in one or more components of the study: MRI {n = 22), EEG (n = 5), neurological exam (n = 5), absolute CD4 count (n = 1), invalid neuropsychoiogical data (n = 4). These 35 participants were distributed proportionately across sites (likelihood ratio (13, N = 35) = 19.91, p = .098). They did not differ from the 298 included in the analysis in age (r = -.597, df= 331, p = .551) or in parent education (used as a measure of socioeconomic status; r = .432, df = 331, p = .666), but there were differences in HIV status. Fewer HIV-children and more HIV+ children with CD4 > 200 were excluded than expected (X 2 (2, N = 35) = 7.28, p = .026). Participants with greater immunosuppression, that is, HIV+ children with CD4 < 200, were not excluded disproportionately from the analysis.
Procedures
The neurological examinations included assessments of muscle bulk, cranial nerve and motor functions, reflexes, and coordination and gait. Abnormalities in muscle bulk were recorded as hemophilia-related if an adjacent joint had acute or chronic changes due to intra-articular hemorrhages; otherwise the abnormality was recorded as nonhemophilia-related. The examinations were performed by pediatric neurologists, pediatricians, or nurse-clinicians. Examiners were not uniformly blinded to participants' HIV status.
The neuropsychoiogical examination was designed to assess performance in nine functional areas (see Appendix). The order of test administration was predetermined, and all measures were administered and scored using standardized procedures. The examinations were performed by psychologists or psychological examiners experienced in conducting standardized assessments with children and adolescents. Examiners were not uniformly blinded to participants' HIV status. Parents, legal guardians, or in some cases older participants were interviewed to obtain developmental and educational histories and parents' level of formal education. At the end of the session, examiners rated the validity of the data in each functional area on a scale of 1 (valid) to 4 (invalid). The present analysis included only the results that were considered to be valid estimates of participants' abilities.
MRIs were performed at each of the hemophilia centers and reviewed independently by two neuroradiologists in the study group. If discrepancies occurred between the readers, a third neuroradiologist reviewed the films to resolve the disagreement. Reviewers were blinded to participants' HIV status. EEGs were obtained; 76% received a first reading locally by a neurologist at the participating center who was not always blinded to HIV status of the subject. The remaining 24% received a first reading centrally by a neurologist blinded to HIV status. Each tracing was then reviewed centrally by a second neurologist blinded to HIV status and to the results of the first reading. A third reading was performed centrally by a neurologist (also blinded to HIV status) whenever significant discrepancies occurred between the first two readers, for example, differences in dominant frequency > 1.0 Hz.
Quality Control
Collaborative studies offer several advantages over single-site studies for research into diseases that occur infrequently in the general population. There is greater opportunity to enroll larger samples for study, thus improving the representativeness of the sample and the statistical power, and to standardize research methods across sites, thus reducing the uncertainties inherent in drawing conclusions from independent studies using different methods to study the same phenomena. On the other hand, multicenter studies pose particular difficulties with respect to reliability and completeness of data gathered across sites.
Several quality control procedures were implemented in the HGDS to address these issues. The neurological and neuropsychological examiners attended two-day training sessions to learn the study protocol and to ensure standardization of procedures. Individual neuropsychological records from the participating centers were reviewed by the data coordinating center for errors in scoring, arithmetic, and transferral of data. Records also were chosen randomly from each center and reviewed by one of the Neuropsychology Committee co-chairs. Data quality control procedures for the neurological examinations included range-checking, value table look-up, logical consistency checks, and cross-forms consistency checks. The staff of the data coordinating center routinely provided feedback to the hemophilia centers to maintain reliability and validity of the data. The procedure of multiple, independent readings of the MRIs and EEGs was designed to enhance the reliability of findings across sites.
Covariates and Neurological Variables
HIV status and age (used as a continuous variable) were included as covariates in all models. Additional medical history and environmental variables (Table I) were selected for inclusion to control for their potential influence on neuropsychological test performance. Information was obtained through a review of medical records or in interviews as noted in the table. The covariates labeled "Academic problems" and "Prior diagnosis of psychological dysfunction" were defined operationally (see table notes for details). The MRI and neurological exam variables (Table II) were chosen from earlier reports of baseline findings in the HGDS (Bale, Contant, Garg, Tilton, Kaufman, & Wasiewski, 1993; Mitchell et al., 1993) . Diffuse cerebral atrophy accounted for the majority of abnormalities found on the baseline MRI scans. Other types of pathology, including congenital abnormalities, old hemorrhagic lesions, and focal atrophy, occurred too infrequently for inclusion in this analysis but are the subject of ongoing analyses in the HGDS.
Statistical Methods
The primary purpose of the analysis was to determine whether there was a difference in mean baseline neuropsychological test scores by HIV status, age, and neurological findings (Table II) , adjusting for selected covariates (Table I) . Standard scores or scaled scores were used for all measures with agereferenced norms; total raw scores were used otherwise (see Appendix, Note, for details). The analysis involved two steps, both utilizing least squaresmodeling. In step one, the covariates were regressed on the individual neuropsychological test scores to determine significant covariates for each functional area shown in the Appendix. Age and HIV status were kept in the models regardless of their significance. Covariates were removed from each model using a step-down approach until only covariates significant at p s .05 (using ANOVA table F-statistics) remained. The covariates that remained in a majority of models for the individual neuropsychological test scores within each functional area (e.g., for three of the five scores within the Language area) were considered to be covariates for that functional area.
In step two, the neurological variables (Table II) were combined with the functional area covariates and all two-way interactions with cell counts of 5 or more to determine final functional area models. Again using a step-down approach, nonsignificant terms were removed from the models until only main effects of neurological variables with p =£ .05 and interactions with p ^ .10 remained (ANOVA table F-tests). The terms that remained in the major- nal model for Full Scale IQ, is presented in Table III . At this step of the analysis, we chose to lower the alpha levels to adjust for multiple comparisons, so that in the final models, only main effects with p < .01 and interactions with p s .05 were considered significant. The strategy of using lower alpha levels in the final step, combined with the previous requirement that a majority of models within each functional area meet criteria for significance, was designed to reduce the possibility of Type I error in these complex analyses. Two-tailed r-tests and tests for differences in proportions (reported as z-statistics in the Results) were used as necessary to examine unadjusted differences between groups in the analysis.
Results
Characteristics of Participants
Sixty percent of participants in this analysis were HIV+ (Table I) ; they were older than the HIV-par- ticipants (mean age = 13 vs. 11 yrs; t= -5.82, df = 296, p < .0001). It is estimated that HIV began to appear in the blood supply in 1978 and that transmission of the virus via factor concentrates occurred rarely after viral-inactivated, donor-screening concentrates became widely available in 1985 (Brookmeyer & Goedert, 1989) . Thus, the younger children were exposed for a shorter interval of time relative to the older participants. The HIV+ participants also were more likely to have severe hemophilia (clotting factor level < 1%) than the HIV-individuals (z = -4.18, p < .001). Severe hemophilia usually requires more frequent treatments for hemophilia-related medical problems, thus greater opportunity for exposure to HIV.
Parents' education ranged from 0 to 20 years of formal schooling (Table I) ; both the mean and median were approximately 12 years of formal education. Developmental milestones for speech and walking were achieved within age expectations in the majority of participants. Seizures and neurological infections were documented for s 10% and < 6% of the sample, respectively. Histories of gait disturbance and intracranial hemorrhage were found for subsets of the sample in all three categories of HIV status. Relatively common findings for all participants included histories of head trauma, academic problems, and diagnosis of psychological dysfunction. These latter three findings may be related to the need for prompt diagnosis and treatment of hemophilia-related medical problems and to school absences.
Neurological and Neuropsychological Findings
Abnormal or equivocal appearance on the MRI (Table II) were found more frequently in the HIV+ participants with CD4 < 200 compared to the HIV-(z = -3.29, p < .001) and HIV+ children with CD4 > 200 (z = -2.73, p = .006). The same pattern was found for diffuse atrophy when the HIV+ group with CD4 < 200 were compared to the HIV-(z = -4.09, p < .0001) and HIV+ group with CD4 => 200 (z = -3.80, p = .0001). These findings support Hypothesis 1. Decreases in muscle bulk were found more frequently in the HIV+ group with CD4 < 200 than in the HIV-group (z = -2.32, p = .02); the HIV+ participants with CD4 s 200 did not differ from the HIV-participants (z = -.69, p = .49). Coordination and/or gait abnormalities were present in approximately 28% of the HIV-group versus .021 N = 291 due to missing data for the covariates (see Table 1 ). "Defined as having repeated a grade or current placement in remedial special education class. 21% (CD4 s 200) and 24% (CD4 < 200) in the HIV+ groups, contrary to Hypothesis 1. This finding indicates that coordination and/or gait abnormalities reflect hemophilia-related morbidity not HIV-related neurological decline. In contrast to these abnormal findings, reflex and cranial nerve function and baseline EEGs were normal in approximately 90% of the sample, regardless of HIV category.
The participants were at age level for general intelligence (Table IV ). Significant differences in general intelligence (using two-tailed r-tests) were found when academic problems or prior head trauma were present. Performance also was lowered when coordination and/or gait abnormalities were present, supporting Hypothesis 2. The covariates shown in Table V were significantly related to neuropsychological performance (at p == .05) across functional areas. A history of academic problems was related to poorer performance in all areas except the Behavioral/Emotional area. Parents' level of formal education was related to their children's performance in all areas except Fine Motor and Behavioral/Emotional. A history of head trauma was related to poorer performance on the measures comprising the General Intelligence, Language, and Visual-Spatial areas, and prior diagnosis of psychological dysfunction was related to parents' reports in the Behavioral/Emotional area. It is important to note that the remaining covariates shown in Table  I , including hemophilia severity and intracranial hemorrhage, were not significantly related to neuropsychological test performance.
We used least squares modeling procedures in the final step of the analysis to compare the means of the neuropsychological measures by neurological variables (Table II) and by individual functional area covariates (Table V) . Variables significantly associated with neuropsychological performance (at p . 01) were academic problems (for all areas except Behavioral/Emotional), coordination and/or gait abnormalities (for the Memory, Attention, and Academic areas), and parents' education (for Language, Memory, and Attention). Age was significantly related to performance in the Language and Academic areas, history of head trauma for the Language measures, and prior diagnosis of psychological dysfunction in the Behavioral/Emotional area. Contrary to Hypothesis 1, HIV status was not significantly associated with neuropsychological performance at baseline. As shown in Table VI, significant interactions (p < .05) among the covariates and neurological findings were found in the General Intelligence, Language, Memory, and Academic functional areas (Hypothesis 3). Although there were two significant interactions in the Behavioral/Emotional area, the range of scores on this measure was so narrow that the differences are not clinically meaningful. We examined the data for evidence of site differences that may have influenced the results and found that site differences do not affect the conclusions presented in this paper. 
Discussion
Hypothesis 1 was partially supported in that the HIV+ participants with CD4 < 200 differed from the HIV-and HIV+ with CD4 > 200, but this difference occurred only for the MRI variables. The hypothesis that cognitive performance would be lower for individuals with abnormalities on the neurological examination (Hypothesis 2) was supported only for the coordination and/or gait variable. On the other hand, lowered performance on the cognitive measures was associated with the following covariates: academic problems, history of head trauma, and parents' level of formal education. With the exception of coordination and/or gait abnormalities, abnormal findings on the MRI and neurological examination were not associated with poorer neuropsychological performance unless combined in interaction with coordination and/or gait abnormalities, parents' education, or previous head trauma. The number of subjects for each of these interactions was small, particularly at the extremes of the measures, influencing the reliability of the findings.
A documented history of head trauma and neurological examination findings of coordination and/or gait abnormalities were relatively common in all groups, regardless of HIV status, and these are the variables that were associated with lowered neuropsychological performance. It is possible that the coordination and/or gait abnormalities observed in the participants with CD4 < 200 resulted from HIV infection, but further investigation into the nature of the coordination and/or gait abnormalities in our sample showed that the findings were not related to HIV but to hemophilia (Usner et al., 1996) . Thus, our findings suggest that hemophilia-related morbidity has an adverse influence on cognitive performance, consistent with previous studies (Loveland et al., 1994; Sirois & Hill, 1993; Whitt et al., 1993) .
The present findings of subtle yet statistically significant differences in cognitive development for children with hemophilia-related coordination and/or gait abnormalities suggest that performance on the coordination and gait component of the neurological examination provides an estimate of the degree of functional severity of hemophilia for children and adolescents. Furthermore, our findings point to the importance of prompt treatment of bleeds as they occur, for the use of prophylactic therapy whenever indicated, and for the need to include periodic evaluation of cognitive and behavioral development as part of the standard of care for pediatric patients with hemophilia. Each of these strategies will enhance efforts to minimize the potential for hemophilia-related co-morbidities as children grow into adulthood.
Although HIV enters the brain shortly after infection, neuropsychological dysfunction has not been invariably found in asymptomatic individuals (Brew, 1993; Johnson, 1994; Perry, 1990) . The results of this study suggest several questions concerning the resilience of neuropsychological functioning in asymptomatic persons with HIV infection.
Is the apparent resilience of neuropsychological functioning related to the sensitivity or specificity of the neuropsychological tests? Postmortem studies of HIV+ individuals have shown relative sparing of the cerebral cortex, the most prominent pathology being subcortical (Perry, 1990) . The neuropsychological tests employed in the HGDS measure primarily cortical functioning and are relatively insensitive to subcortical pathology. Thus, it is possible that the neuropsychological procedures used in the HGDS were not sufficiently sensitive to early signs of HIV-associated neuropsychological dysfunction at baseline. Furthermore, our definition of HIV disease progression (as defined by CD4 count above or below 200) may not have permitted us to focus on the subgroup of HIV+ participants with the most severe immunocompromise. The longitudinal data analyses will include a definition reflecting changes in CD4 cell counts over time, perhaps providing greater capability to detect subtle "Includes prior diagnoses of learning disability/dyslexia, attention deficit/hyperactivity, developmental language delay, conduct disorder/ oppositional, depression, personality disorder, eating or sleeping disorder, enuresis/encopresis, and motor impairment.
changes in neuropsychological performance. Our findings might also be biased if children severely ill with HIV did not enroll in the study. The HGDS is a population-based cohort study with a high rate of enrollment among eligible children and adolescents (Hilgartner et al., 1993) . The cohort's clinical status at baseline, with respect to the presence of AIDSdefining conditions (CDC, 1987) , was similar to that reported in a large cohort study for a similarly aged group of individuals with hemophilia . For these reasons, we believe it is unlikely that failure to demonstrate differences in neuropsychological function between the HIVand HIV+ participants was due to an inherent bias in enrollment in our study group. Is there a critical threshold that must be crossed before the cumulative effects of advancing illness can be detected? Percolation theory, discussed by Nadel (1990) , predicts that little change in performance will be noted until structural changes cross a critical threshold, at which time an abrupt change takes place. Our data suggest that cognitive performance may be lowered when a combination of neurological abnormalities and environmental conditions coexist. A decline in neuropsychological performance coincident with increasing symptoms of medical illness or progression to AIDS, or a terminal drop in performance shortly before death, is consistent with this concept. Analysis of the neuropsychological performance of HGDS participants relative to timing of illness or death may answer this question.
Do environmental factors play a role in maintenance of cognitive stability? Sameroff and Chandler (1975) found that children suffering brain damage at birth often develop normally if they are reared in supportive homes. Parents' education is an important factor in their definition of a supportive home, and our finding that parents' education was related to cognitive performance is consistent with their work. The parents in the HGDS had 12 years of formal education on the average; thus, it may be that our sample reflects development in relatively privileged circumstances.
Are there protective factors related to developmental changes occurring in individuals in the age range studied? Studies of individuals who acquired HIV through blood transfusion or clotting factor concentrates (Eyster, 1991) indicate that progression to AIDS occurred most slowly among those infected between the ages of 1 and 18 years compared to those infected at younger or older ages. Survival rate, regardless of CD4 count, was found to be higher in hemophilic individuals infected with HIV before the age of 18 (Ehmann, Eyster, Wilson, Andes, & Goedert, 1994) . The HIV+ participants in the HGDS were all infected before age 18; thus, the findings of normal cognitive performance in our sample of relatively healthy 7-to 19-year-olds are consistent with previous reports.
Is the finding of normal neuropsychological performance in the HGDS cohort a function of sample characteristics? Individuals with conditions such as severe developmental or psychiatric disorders were excluded from participation in the study, thus restricting the range of neuropsychological performance in the cohort to a level slightly above the mean for age at baseline. This result does not reflect a sample bias but rather is consistent with Whitt et al.'s (1993) findings of normal performance in a sample of hemophilic children and adolescents that was not subject to exclusion criteria. In addition, the fact that our sample was well within normal limits at baseline provides an important foundation to support the longitudinal analyses of HGDS data. We will have the opportunity to investigate potential changes in performance in either direction without the confounding difficulties of ceiling and floor effects in neuropsychological assessment. We expect to find improvements in performance due to repeated experience with the test materials, and we hypothesize future decrements in performance due to the adverse influences of advancing HIV disease on neurological functioning.
Interpretation of the baseline data from the HGDS is limited by the fact that the data were collected at only one point in time, yet these crosssectional data provide a potential pattern to show how young people with compromised immune function will develop as HIV disease progresses. The data collected at the baseline exam indicate that cognitive performance was at age level after a median of approximately 7 years following infection, despite the presence of neurological abnormalities and increasing compromise of the immune system. The HIV+ hemophilic cohort in this study is therefore similar to many HIV+ young adults in that neuropsychological performance is within age expectations even after a relatively long period of time following seroconversion. This pattern is markedly different from the pattern of rapid decline shown by many infants infected through vertical transmission from their HIV+ mothers. A second limitation of the study is the lack of data pertaining to school attendance prior to study enrollment. Information about school absences would aid interpretation of the neuropsychological data and improve our understanding of the functional severity of hemophilia in childhood and adolescence.
Neuropsychological assessment has been used effectively in the past to investigate meaningful differences in performance among groups of HIVand HIV+ individuals of varying ages and with varying degrees of symptomatology. Neuropsychological measures have also been used to demonstrate treatment effects of antiretroviral medication in HIV+ pediatric patients (Connor, 1991) . The longitudinal analyses of HGDS data will include measures of physical health, for example, changes in CD4 count and occurrence of AIDS-defining conditions, that should illuminate the relationship between neuropsychological functioning and progression of HIV disease. If the percolation theory is applicable to this situation, then we would expert to find more frequent or more severe deficits occurring as the children's medical condition deteriorates. The longitudinal data of the HGDS will provide more information concerning the cumulative effects of HIV disease on brain functioning in a pediatric population.
